From: Cerebrospinal fluid pleocytosis level as a diagnostic predictor? A cross-sectional study
Non-infectious neurological diseases subgroup | CSF leukocytes/μl | |||||||
---|---|---|---|---|---|---|---|---|
≤10 | >10–50 | >50–100 | >100–200 | >200–400 | >400–600 | >600 | Total | |
n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
Encephalitis/myelitis, non-infectious | 8 (66.7) | 2 (16.7) | 1 (8.3) | 1 (8.3) | 12 (100.0) | |||
Seizures/epilepsy/status epilepticus | 2 (33.3) | 4 (66.7) | 6 (100.0) | |||||
Ischemia/infarction/stroke | 4 (36.3) | 4 (36.6) | 1 (9.1) | 2 (18.2) | 11 (100.0) | |||
Intracranial haemorrhage | 1 (50.0) | 1 (50.0) | 2 (100.0) | |||||
Multiple sclerosis | 8 (53.3) | 7 (46.7) | 15 (100.0) | |||||
Demyelinating disease/polyneuropathy | 2 (40.0) | 3 (60.0) | 5 (100.0) | |||||
Paralysis/palsy of cranial nerve | 2 (66.7) | 1 (33.3) | 3 (100.0) | |||||
Headache/migraine | 3 (60.0) | 2 (40.0) | 5 (100.0) | |||||
Other neurological | 11 (55.0) | 5 (25.0) | 1 (5.0) | 1 (5.0) | 1 (5.0) | 1 (5.0) | 20 (100.0) | |
Total | 32 (40.5) | 34 (43.0) | 3 (3.8) | 6 (7.6) | 2 (2.5) | 1 (1.3) | 1 (1.3) | 79 (100.0) |